Nephrocare Healt

  • Market Cap: N/A
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
715.05
18.9 (2.71%)
BSENSE

Aug 11

BSE+NSE Vol: 65.72 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039897,
    "name": "Nephrocare Healt",
    "stock_name": "Nephrocare Healt",
    "full_name": "Nephrocare Health Services Ltd",
    "name_url": "stocks-analysis/nephrocare-healt",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "715.05",
    "chg": 18.9,
    "chgp": "2.71%",
    "dir": 1,
    "prev_price": "696.15",
    "mcapval": "7,190.47 Cr",
    "mcap": "",
    "scripcode": 544647,
    "symbol": "NEPHROPLUS",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE428V01029",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "65.72 k",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/nephrocare-healt-10039897-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Nephrocare Health Services Ltd Upgraded to Hold on Improved Financial and Quality Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nephrocare-health-services-ltd-upgraded-to-hold-on-improved-financial-and-quality-metrics-4002342",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NephrocareHealt_mojoScore_4002342.png",
        "date": "2026-05-21 08:31:30",
        "description": "Nephrocare Health Services Ltd has been upgraded to a Hold rating with a Mojo Score of 64.0, reflecting significant improvements in its financial trend and quality parameters. The healthcare services company, operating as a small-cap stock, has demonstrated robust quarterly performance and enhanced institutional interest, despite a recent 5.55% dip in its share price. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that have driven this rating change as of 20 May 2026."
      },
      {
        "title": "Nephrocare Health Services Ltd Quality Grade Upgrade Signals Improved Business Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nephrocare-health-services-ltd-quality-grade-upgrade-signals-improved-business-fundamentals-4002018",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NephrocareHealt_qualitydot_4002018.png",
        "date": "2026-05-21 08:00:32",
        "description": "Nephrocare Health Services Ltd has seen its quality grade upgraded from \"Does Not Qualify\" to \"Good\" by MarketsMOJO, reflecting notable improvements in its business fundamentals. Despite a recent 5.55% decline in share price, the healthcare services company demonstrates strengthening operational metrics and financial discipline, positioning it as a noteworthy small-cap in the sector."
      }
    ],
    "total": 2,
    "sid": "10039897",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/nephrocare-health-services-10039897"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations 2015",
      "datetime": "05-Aug-2026",
      "details": "Please find enclosed the Trading Plans dated August 05 2026 received from Designated Persons of the company and same have been approved by the compliance officer.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "24-Jul-2026",
      "details": "Pursuant to Regulation 30 of the SEBI Listing Regulations we hereby inform you that the Company has scheduled an Investor Result Conference Call on Wednesday 12th August 2026 at 10:00 A.M IST to discuss the Unaudited Financial Results of the Company for the quarter ended 30th June 2026. A copy of the invitation is also attached for your information",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for The Company Has Informed BSE That The Meeting Of The Board Of Directors Is Scheduled On 11/08/2026 Inter Alia To Consider And Approve The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter E",
      "datetime": "24-Jul-2026",
      "details": "Nephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11-08-2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(11 Aug 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations 2015

05-Aug-2026 | Source : BSE

Please find enclosed the Trading Plans dated August 05 2026 received from Designated Persons of the company and same have been approved by the compliance officer.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

24-Jul-2026 | Source : BSE

Pursuant to Regulation 30 of the SEBI Listing Regulations we hereby inform you that the Company has scheduled an Investor Result Conference Call on Wednesday 12th August 2026 at 10:00 A.M IST to discuss the Unaudited Financial Results of the Company for the quarter ended 30th June 2026. A copy of the invitation is also attached for your information

Board Meeting Intimation for The Company Has Informed BSE That The Meeting Of The Board Of Directors Is Scheduled On 11/08/2026 Inter Alia To Consider And Approve The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter E

24-Jul-2026 | Source : BSE

Nephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11-08-2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

(11 Aug 2026)

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available